Zobrazeno 1 - 10
of 208
pro vyhledávání: '"Jilong, Yang"'
Autor:
Hairong Xu, Yong Zhou, Li Liang, Jingnan Shen, Wangjun Yan, Jin Wang, Jianmin Li, Xiaojing Zhang, Gang Huang, Wenzhi Bi, Zheng Guo, Yanbin Xiao, Jianhua Lin, Weitao Yao, Zhichao Tong, Wenxian Zhou, Guochuan Zhang, Zhaoming Ye, Dong Wang, Jilong Yang, Zhengfu Fan, Caigang Liu, Guofan Qu, Qing Zhang, Feng Wei, Weifeng Liu, Chongqi Tu, Hong Li, Jing Yuan, Xiaohui Niu
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-9 (2024)
Abstract This was a multicenter, single-arm, open-label, phase Ib/II study (NCT04255576), aimed to evaluate the efficacy and safety of JMT103 in patients with unresectable or surgically-challenging giant cell tumor of bone (GCTB). JMT103 (2 mg/kg) wa
Externí odkaz:
https://doaj.org/article/55d90559901a45d7b87e4d04f7225e5a
Publikováno v:
Asian Review of Political Economy, Vol 3, Iss 1, Pp 1-8 (2024)
Abstract This special issue explores the relationship between digital trade and security, emphasizing the geopolitical implications for the global economy in the digital age. The rapid growth of digital trade has introduced significant challenges and
Externí odkaz:
https://doaj.org/article/2f34bda542e84bf180e17d0d46f51488
Autor:
Peipei Xing, Haotian Liu, Wanyi Xiao, Gengpu Zhang, Chao Zhang, Zhichao Liao, Ting Li, Jilong Yang
Publikováno v:
Cell Death Discovery, Vol 10, Iss 1, Pp 1-11 (2024)
Abstract Through transcriptome sequencing, we previously identified a new osteosarcoma-specific, frequent fusion gene, LRP1–SNRNP25, and found that it played an important role in tumor cell invasion and migration. However, the specific mechanism re
Externí odkaz:
https://doaj.org/article/62a3a795f33f400eab21be4bff4d8da6
Publikováno v:
Cancer Biology & Medicine, Vol 21, Iss 2, Pp 125-131 (2024)
Externí odkaz:
https://doaj.org/article/fe790c087ad249ffa19ef5c897a66ceb
Autor:
Yijia Guo, Lihua Zhu, Liyin Zhang, Xinxin Tang, Xinjie Li, Yiming Ge, Feng Li, Jilong Yang, Shaoyou Lu, Jinru Chen, Xiaotao Zhou
Publikováno v:
Toxics, Vol 12, Iss 9, p 634 (2024)
The risk of occupational exposure to organic solvents varies across industries due to factors such as processing materials, ventilation conditions, and exposure duration. Given the dynamic nature of organic solvent use and occupational exposures, con
Externí odkaz:
https://doaj.org/article/44ca6d61547f4559817a34090985666f
Autor:
Zhao Wang, Menghan Luo, Qian Liang, Ke Zhao, Yuelin Hu, Wei Wang, Xiangling Feng, Bolang Hu, Jianjin Teng, Tianyi You, Ran Li, Zhengkai Bao, Wenhao Pan, Tielong Yang, Chao Zhang, Ting Li, Xiaobao Dong, Xianfu Yi, Ben Liu, Li Zhao, Miaoxin Li, Kexin Chen, Weihong Song, Jilong Yang, Mulin Jun Li
Publikováno v:
Genome Biology, Vol 24, Iss 1, Pp 1-32 (2023)
Abstract Background The high mutation rate throughout the entire melanoma genome presents a major challenge in stratifying true driver events from the background mutations. Numerous recurrent non-coding alterations, such as those in enhancers, can sh
Externí odkaz:
https://doaj.org/article/ea2c5d7f313e4e34877e64882a16ffd9
Autor:
Zhichao Liao, Jianjin Teng, Tao Li, Haotian Liu, Ting Li, Chao Zhang, Ruwei Xing, Sheng Teng, Yun Yang, Jun Zhao, Wanyi Xiao, Gengpu Zhang, Mulin Jun Li, Weitao Yao, Jilong Yang
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundSarcoma is a highly heterogeneous malignancy with a poor prognosis. Although chemotherapy and targeted therapy have improved the prognosis to some extent, the efficacy remains unsatisfactory in some patients. The efficacy and safety of immu
Externí odkaz:
https://doaj.org/article/9a44e26d31ed4aea83d878e10b23e41a
Autor:
Chao Zhang, Hongru Shen, Tielong Yang, Ting Li, Xinyue Liu, Jin Wang, Zhichao Liao, Junqiang Wei, Jia Lu, Haotian Liu, Lijie Xiang, Yichen Yang, Meng Yang, Duan Wang, Yang Li, Ruwei Xing, Sheng Teng, Jun Zhao, Yun Yang, Gang Zhao, Kexin Chen, Xiangchun Li, Jilong Yang
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-14 (2022)
Studying the cell composition of acral melanoma at the single-cell level could provide some clues about its poor response to immunotherapy. Here, the authors analyse acral and cutaneous melanoma patient samples using single-cell RNA-sequencing, and r
Externí odkaz:
https://doaj.org/article/669ad832d29f41e1866555df7dad9271
Publikováno v:
Cancer Biology & Medicine, Vol 19, Iss 10, Pp 1496-1502 (2022)
Externí odkaz:
https://doaj.org/article/2628b5ad7c334906a4c5c6a2342af4ec
Publikováno v:
Cancer Biology & Medicine, Vol 19, Iss 8, Pp 1211-1223 (2022)
Objective: The BRAF inhibitor, vemurafenib, has been widely used in the treatment of patients with melanoma-bearing BRAFV600E mutations. While the initial response to vemurafenib is usually excellent, the majority of patients eventually develop resis
Externí odkaz:
https://doaj.org/article/a4c7194c32844833b7fac0b3b5911027